Company / EPS (Diluted)
Mettler Toledo EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$35.90
FY2025
5-year range
$22.47 / $38.41
FY2021-FY2025
Trend
-6.5%
vs FY2024
Sector context
#1 of 159
Health Care
What the data says
Among 159 Health Care companies, Mettler Toledo is in the top 1% for eps (diluted). EPS (Diluted) has fluctuated over the past 10 years, ranging from $14.22 in FY2016 to $38.41 in FY2024.
Based on SEC 10-K filings.
35.90 in FY2025 with a 5-year CAGR of +12.5%. Ranks 1st among 159 companies in Health Care.
Improved from $32.78 to $35.90 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +13.0%
- 5-Year CAGR
- +12.5%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 159This company $35.90 Sector average $1.56
▼
+2206.2% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 6.5% year-over-year.
- Ranks #1 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.22 (safe zone, above 2.9 threshold)
- Strong profit margin: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.90 | -6.5% |
| FY2024 | $38.41 | +17.2% |
| FY2023 | $32.78 | +31.6% |
| FY2022 | $24.91 | +10.9% |
| FY2021 | $22.47 | +13.0% |
| FY2020 | $19.88 | +39.6% |
| FY2019 | $14.24 | -28.4% |
| FY2018 | $19.88 | +39.6% |
| FY2017 | $14.24 | +0.1% |
| FY2016 | $14.22 | +13.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026